tiagabine has been researched along with Anxiety Disorders in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 16 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chow, C; Dougherty, DD; Evans, KC; Fischman, AJ; Gold, AL; Hoge, EA; Kaufman, RE; Pollack, MH; Rauch, SL; Simon, NM; Worthington, JJ | 1 |
| Karakatsanis, NA; Karapoulios, E; Kouzoupis, AV; Masdrakis, VG; Oulis, P; Papadimitriou, GN | 1 |
| Spielmans, GI | 1 |
| Schwartz, TL | 1 |
| Lydiard, RB | 1 |
| Crane, D | 1 |
| Rosenthal, M | 1 |
| Stahl, SM | 1 |
| Rupprecht, R; Zwanzger, P | 1 |
| Barenbaum, RD; Rilla Manta, L | 1 |
| Rawlings, D; Schaller, JL; Thomas, J | 1 |
| Brown, C; Ondrasik, J; Pollack, MH; Rickels, K; Roy-Byrne, PP; Snyder, H; Van Ameringen, M | 1 |
| Carpenter, LL; Haggarty, R; Mello, AF; Mello, MF; Price, LH; Schecter, JM; Tyrka, AR | 1 |
| Nihalani, N; Schwartz, TL | 1 |
| Dunlop, BW; Garlow, SJ; Knight, BT; Ninan, PT; Papp, L; Weiss, PS | 1 |
| Pollack, MH; Tiller, J; Trivedi, MH; Xie, F | 1 |
3 review(s) available for tiagabine and Anxiety Disorders
| Article | Year |
|---|---|
The role of GABA in anxiety disorders.
Topics: Acetates; Amines; Anxiety Disorders; Benzodiazepines; Cyclohexanecarboxylic Acids; GABA Agents; Gabapentin; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Nipecotic Acids; Receptors, GABA-A; Synaptic Transmission; Tiagabine | 2003 |
Anticonvulsants as anxiolytics, part 1: tiagabine and other anticonvulsants with actions on GABA.
Topics: Anti-Anxiety Agents; Anticonvulsants; Anxiety Disorders; Carbamazepine; Fructose; GABA Agonists; gamma-Aminobutyric Acid; Humans; Lamotrigine; Nipecotic Acids; Synapses; Tiagabine; Topiramate; Triazines; Valproic Acid | 2004 |
Tiagabine in anxiety disorders.
Topics: Anxiety Disorders; Female; GABA Agonists; gamma-Aminobutyric Acid; Humans; Male; Nipecotic Acids; Randomized Controlled Trials as Topic; Stress Disorders, Post-Traumatic; Tiagabine | 2006 |
6 trial(s) available for tiagabine and Anxiety Disorders
| Article | Year |
|---|---|
A PET study of tiagabine treatment implicates ventral medial prefrontal cortex in generalized social anxiety disorder.
Topics: Adult; Anxiety Disorders; Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Neurotransmitter Uptake Inhibitors; Nipecotic Acids; Positron-Emission Tomography; Prefrontal Cortex; Tiagabine | 2009 |
Tiagabine for the treatment of anxiety.
Topics: Adult; Anxiety Disorders; Female; GABA Agonists; Humans; Male; Middle Aged; Neurotransmitter Uptake Inhibitors; Nipecotic Acids; Tiagabine; Treatment Outcome | 2003 |
Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Anxiety Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; GABA Agonists; Humans; Male; Middle Aged; Nipecotic Acids; Paroxetine; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Sleep; Tiagabine; Treatment Outcome | 2003 |
The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study.
Topics: Adult; Aged; Anxiety Disorders; Data Interpretation, Statistical; Double-Blind Method; Drug Administration Schedule; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Neurotransmitter Uptake Inhibitors; Nipecotic Acids; Outcome Assessment, Health Care; Placebos; Psychiatric Status Rating Scales; Tiagabine; Treatment Outcome | 2005 |
Open-label tiagabine monotherapy for major depressive disorder with anxiety.
Topics: Adult; Ambulatory Care; Anxiety Disorders; Comorbidity; Depressive Disorder, Major; Drug Administration Schedule; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Neurotransmitter Uptake Inhibitors; Nipecotic Acids; Pilot Projects; Psychiatric Status Rating Scales; Tiagabine; Treatment Outcome | 2006 |
Tiagabine for social anxiety disorder.
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Double-Blind Method; Ethnicity; Female; GABA Agents; Humans; Male; Middle Aged; Nipecotic Acids; Pilot Projects; Psychiatric Status Rating Scales; Secondary Prevention; Social Behavior Disorders; Tiagabine | 2007 |
7 other study(ies) available for tiagabine and Anxiety Disorders
| Article | Year |
|---|---|
For publication: Tiagabine in the discontinuation of long-term benzodiazepine use.
Topics: Aged; Anxiety Disorders; Benzodiazepines; Bromazepam; Female; GABA Agonists; Humans; Hypnotics and Sedatives; Nipecotic Acids; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome; Tiagabine | 2009 |
Questionable tolerability of tiagabine in generalized anxiety disorder.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Humans; Nipecotic Acids; Tiagabine | 2009 |
The use of tiagabine augmentation for treatment-resistant anxiety disorders: a case series.
Topics: Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Drug Resistance; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Nipecotic Acids; Stress Disorders, Post-Traumatic; Tiagabine | 2002 |
Vigabatrin and tiagabine might have antipanic properties.
Topics: Anti-Anxiety Agents; Anticonvulsants; Anxiety Disorders; Clinical Trials as Topic; Humans; Nipecotic Acids; Tiagabine; Vigabatrin | 2004 |
[New molecular targets in pharmacological treatment of anxiety disorders].
Topics: Anxiety Disorders; Benzodiazepines; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Molecular Biology; Nipecotic Acids; Pregabalin; Receptors, GABA; Tiagabine | 2004 |
Low-dose tiagabine effectiveness in anxiety disorders.
Topics: Adolescent; Adult; Animals; Anxiety; Anxiety Disorders; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Neurotransmitter Uptake Inhibitors; Nipecotic Acids; Tiagabine; Treatment Outcome | 2004 |
Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; GABA Agonists; Humans; Male; Middle Aged; Nipecotic Acids; Personality Inventory; Randomized Controlled Trials as Topic; Tiagabine; Treatment Outcome | 2008 |